Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2008
11/19/2008CN101306115A Decoction for treating acute urticaria
11/19/2008CN101306113A External drug for treating scabies
11/19/2008CN101306111A Medicaments for treating animal trauma
11/19/2008CN101306109A Medicaments for treating pet burn and scald
11/19/2008CN101306108A Decoction for treating greasiness seborrheic dermatitis
11/19/2008CN101306097A Zengkangning tablets quality control method
11/19/2008CN101306096A Decoction for treating chronic eczema
11/19/2008CN101306085A External drug for treating tinea on manus and pedes of squamus and vesiclar type
11/19/2008CN101306075A Decoction for treating psoriasis vulgaris
11/19/2008CN101306027A Extracting method of medical mangrove acanthus total flavonoids
11/19/2008CN101306023A New use of spikemoss extract
11/19/2008CN101306016A Medicine for treating foot odor
11/19/2008CN101305982A 局部凝胶给药体系 Topical gel delivery system
11/19/2008CN100434421C Substituted propane-1,3-diamine derivatives and the pharmaceutical use
11/19/2008CN100434115C Powder containing tuckahoe, seed of gordon euryale, coix seed and lotus seed
11/19/2008CN100434111C Powder containing seed of spine date, licorice and wheat
11/19/2008CN100434110C Powder comprising mint and chrysanthemum
11/19/2008CN100434102C Medicine for treating scalds
11/19/2008CN100434097C Ophidia black snake powder
11/19/2008CN100434086C Burn medicine
11/19/2008CN100434083C Medicinal use of fugu cod liver oil
11/19/2008CN100434080C A medicine for treating dermatosis
11/19/2008CN100434068C Bexarotene gel and its preparation method
11/18/2008US7453010 trans-N-{5-[((2S)-3-{[4-(1,1'-Biphenyl-4-yl)cyclohexyl]amino}-2-hydroxypropyl)oxy]-2-hydroxyphenyl}methanesulfonamide; beta 3 receptor agonists; antiinflammtory agent; irritable bowel syndrome; obesity, diabeties, glaucoma, dysmenorrheal, depression, urinary incontinence, lipolysis or cicatrizing
11/18/2008US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα
11/18/2008US7452976 Immunoglobulin specific to kinase insert domain-containing receptor (KDR) for use in treatment and prevention of inflammation, psoriasis, rheumatoid arthritis and tumor growth; immunotherapy
11/18/2008US7452912 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
11/18/2008US7452884 Methods for inhibiting angiogenesis
11/18/2008US7452873 Inhibitors of GSK-3 and uses thereof
11/18/2008US7452864 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media
11/18/2008US7452557 Preventive or therapeutic agent for pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria, or health food for prevention or improvement or reduction of symptoms thereof
11/18/2008US7452556 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride
11/18/2008CA2423659C Antiviral composition and treatment method
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2416147C Dermal application system for aminolevulinic acid
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/18/2008CA2381219C Monomeric protein of the tgf-beta family
11/18/2008CA2362281C Combinations for the treatment of diseases involving angiogenesis
11/18/2008CA2352275C Il-5 inhibiting 6-azauracil derivatives
11/18/2008CA2298349C Antiallergic composition and antipruritic composition
11/18/2008CA2245125C Use of one extract of at least one rosaceae plant
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/14/2008CA2685257A1 Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
11/13/2008WO2008137149A1 Diabetic wound healing
11/13/2008WO2008137137A1 Creatine ascorbyl derivatives and methods of use thereof
11/13/2008WO2008137060A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008135661A2 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008WO2008135548A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris
11/13/2008WO2008135361A2 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
11/13/2008WO2008135232A1 Use and compositions of purine derivatives for the treatment of proliferative disorders
11/13/2008WO2008135169A1 Nucleic acid-containing cosmetic and/or pharmaceutical preparations for treating epithelial tissue
11/13/2008WO2008134919A1 Ejaculum of animals as medicinal material and uses thereof in medicaments for treatment of diseases such as tumors, depression, etc.
11/13/2008WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
11/13/2008WO2008087354A3 Cream-gel comprising at least one retinoid and benzoyl peroxide
11/13/2008WO2008043974A3 Two-compartment skincare products comprising ivermectin, and uses thereof
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008US20080280989 Hydroxybenzamide Derivatives, the Method For Preparing Thereof and the Cosmetic Composition Containing the Same
11/13/2008US20080280987 Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
11/13/2008US20080280967 Antiarthritic agents; antiinflammatory agents; inflammatory bowel disorders; graft verses host disease; antiulcer agents; skin disorders; respiratory system disorders; anticancer agents
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280943 Methods and packages to enhance safety when using imiquimod to treat children diagnosed with skin disorders
11/13/2008US20080280941 8-Phenoxy-Gamma Carboline Derivatives
11/13/2008US20080280934 Porphyrin ring compound containing cyanovinyl group; reacted with Vilsmeier reagent,complexed with metal ion in prsence of an acid and oxidizer; skin disorders; antiinflammatory agents; anticancer agents; antitumor agents; vascular disorders, vision defects, urogenital system disorders; immunology
11/13/2008US20080280918 phosphodiesterase enzyme inhibitor; 4-[(3-chlorophenyl)amino]-2-ethyl-5-(1-hydroxyethyl)-6-phenylpyridazin-3(2H)-one; potent antiinflammatory agent; asthma, atopic dermatitis, psoriasis, chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease
11/13/2008US20080280916 treating and/or preventing skin disorders mediated by stearoyl-CoA desaturase in mammals selected from acne, rosacea and seborrheic skin, comprising administering 6-[4-(2-Trifluoromethylbenzoyl)piperazin-1-yl]pyridazine-3-carboxylic acid (2-phenoxyethyl)amide
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280871 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280856 Fibroblast Activation Protein Inhibitor Compounds and Methods
11/13/2008US20080280852 Composition Containing Fermentable Polysaccharides
11/13/2008US20080280819 Methods for promoting hair growth
11/13/2008US20080280816 Methods and pharmaceutical compositions for healing wounds
11/13/2008US20080279963 Aqueous isotonic solution of hypohalous acid and halide salt; acidity pH; storage stability; active against three types of Staphlococcus
11/13/2008US20080279939 Using a mixture of tissue sources; regeneration in situ
11/13/2008US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis
11/13/2008US20080279905 Low irritation; containing ethylene-vinyl alcohol fibers and a crystal structure thermp[lastic resin
11/13/2008US20080279869 Method for reducing neuronal degeneration by administering cns-derived peptides or activated t cells
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279842 Surgical bandage comprising proteolytic enzymes incorporated into a degradable polymeric material; less painful removal of damaged tissue
11/13/2008US20080279840 Treating vision and skin disorders with amine oxidase therapeutics
11/13/2008US20080279833 Solid support comprising mammalian extracellular matrix for use in propagation of embryonic stem cell for use in treatment and repair of heart, pancreatic a nd/or liver tissues; tissue engineering and repair; regenerative medicine; wound healing agents
11/13/2008US20080279830 Solid support comprising propagating mesenchymal tissue for use in enhancing recovery from surgery; tissue engineering; regenerative medicine
11/13/2008US20080279824 Articles for tissue regeneration with biodegradable polymer
11/13/2008US20080279820 Compositions and Methods for Treating Burns
11/13/2008US20080276568 Building structure and components thereof
11/13/2008DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can
11/13/2008CA2689608A1 Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
11/13/2008CA2686063A1 Diabetic wound healing
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2684126A1 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
11/13/2008CA2684091A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1988909A2 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
11/12/2008EP1569697B1 Wound dressings comprising vanadate complexed with organic ligands
11/12/2008EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof